{{'Mon, 24 Mar 2025 08:00:00 -0400' | dateFormatUsFilter}}
Novo Nordisk expands Wegovy® $499-per-month offering to additional cash-paying patients via the Wegovy® savings offer
Read more
{{'Mon, 17 Mar 2025 08:00:00 -0400' | dateFormatUsFilter}}
Novo Nordisk presents new semaglutide cardiovascular data across multiple chronic diseases at the American College of Cardiology 74th Annual Scientific Sessions
Read more
{{'Wed, 05 Mar 2025 08:00:00 -0500' | dateFormatUsFilter}}
Novo Nordisk introduces NovoCare® Pharmacy, lowering cost of all doses of FDA-approved Wegovy® (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients
Read more
Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.